FDA Adds Boxed Warning to CAR T-Cell Therapies, but Says Benefits Outweigh Risks of Secondary Cancers.

作者信息

Suran Melissa

出版信息

JAMA. 2024 Mar 12;331(10):818-820. doi: 10.1001/jama.2024.1011.

DOI:10.1001/jama.2024.1011

PMID:38381427

Abstract

摘要

相似文献

[1]

FDA Adds Boxed Warning to CAR T-Cell Therapies, but Says Benefits Outweigh Risks of Secondary Cancers.

JAMA. 2024-3-12

[2]

Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System.

Blood. 2024-5-16

[3]

Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome.

J Clin Oncol. 2017-6-10

[4]

Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs.

Expert Opin Drug Saf. 2013-3-12

[5]

National antidepressant prescribing in children and adolescents with mental health disorders after an FDA boxed warning.

Res Social Adm Pharm. 2014

[6]

The impact of the boxed warning on the duration of use for depot medroxprogesterone acetate.

Pharmacoepidemiol Drug Saf. 2017-7

[7]

A continuing black hole? The FDA boxed warning: an appeal to improve its clinical utility.

Clin Toxicol (Phila). 2011-5-18

[8]

Prescribing Antipsychotic Medications to Patients With Dementia: Boxed Warnings and Mitigation of Legal Liability.

Continuum (Minneap Minn). 2019-2

[9]

Trends in Utilization of Urate-Lowering Therapies Following the US Food and Drug Administration's Boxed Warning on Febuxostat.

Arthritis Rheumatol. 2021-3

[10]

Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.

Ann Pharmacother. 2019-7-18

引用本文的文献

[1]

Smart CAR-T Nanosymbionts: archetypes and proto-models.

Front Immunol. 2025-8-12

[2]

Ann Hematol. 2025-3

[3]

Effect of metachronous primary and secondary solid cancers in patients with multiple myeloma: a retrospective study from a single-center.

Front Immunol. 2025-3-10

[4]

Mitigation and Management of Common Toxicities Associated with the Administration of CAR-T Therapies in Oncology Patients.

Drug Saf. 2025-3-19

[5]

CAR T Cell Nanosymbionts: Revealing the Boundless Potential of a New Dyad.

Int J Mol Sci. 2024-12-7

[6]

CAR-T cell therapy in advanced thyroid cancer: from basic to clinical.

Front Immunol. 2024

[7]

A real-world pharmacovigilance study on cardiovascular adverse events of tisagenlecleucel using machine learning approach.

Sci Rep. 2024-6-13

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

FDA Adds Boxed Warning to CAR T-Cell Therapies, but Says Benefits Outweigh Risks of Secondary Cancers.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献